Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002150272 | SCV002418516 | likely benign | Multiple endocrine neoplasia, type 2 | 2024-06-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003161539 | SCV003869105 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-12-02 | criteria provided, single submitter | clinical testing | The c.447C>T variant (also known as p.F149F), located in coding exon 3 of the RET gene, results from a C to T substitution at nucleotide position 447. This nucleotide substitution does not change the at codon 149. This variant has been reported, in trans with a RET missense variant, in a patient with long-segment familial Hirschsprung's disease (Fitze G et al. Lancet, 2002 Apr;359:1200-5).This nucleotide position is well conserved in available vertebrate species. In silico splice site analysis for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |